LEADER 05612nam 22006375 450 001 9910253949003321 005 20200701224450.0 010 $a981-10-4726-X 024 7 $a10.1007/978-981-10-4726-8 035 $a(CKB)4100000001382029 035 $a(DE-He213)978-981-10-4726-8 035 $a(MiAaPQ)EBC5211336 035 $a(PPN)222226323 035 $a(EXLCZ)994100000001382029 100 $a20171230d2017 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNext Generation Point-of-care Biomedical Sensors Technologies for Cancer Diagnosis /$fedited by Pranjal Chandra, Yen Nee Tan, Surinder P. Singh 205 $a1st ed. 2017. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2017. 215 $a1 online resource (XII, 396 p. 164 illus., 149 illus. in color.) 311 $a981-10-4725-1 320 $aIncludes bibliographical references at the end of each chapters. 327 $aCancer Biomarkers: Important Tools for Cancer Diagnosis and Prognosis -- Transcription factors as detection and diagnostic biomarkers in cancer -- Cancer biomarkers immunosensing strategies based on graphene surface engineered materials -- Label-free biosensors for early diagnosis of cancer based on G-quadruplex and isothermal amplification -- Point-of-care and implantable biosensors in cancer research and diagnosis -- Electrochemical Redox Cycling Amplification Technology for Point-of-Care Cancer Diagnosis -- Hyperbolic metamaterials-based ultra-sensitive plasmonic biosensors for early stage cancer detection -- SERS-based biosensors as potential next generation point-of-care cancer diagnostic platforms -- Nucleic acid-based aptasensors for cancer diagnostics - An insight into immobilisation strategies -- Nanobiosensing technologies for prostate cancer diagnostics/prognostics:  Tiny smart medicine -- Developments in the  Electrochemical Bionanosensors for the Predictive Diagnosis of Prostate and Breast Cancer -- Oligopeptides for Cancer and other Biomedical Sensing Applications -- Microfluidic immunoassay devices as next generation cancer and medical diagnostics platform -- Point-of-care device with plasmonic gold nanoarray sensing chip for biomarker detections -- Sers Biosensing and Bioimaging: Design and Applications in Cancer Diagnostics -- Microfluidic Paper-based Analytical Devices  for Point-of-Care Diagnosis. 330 $aThis book presents recent research on cancer detection methods based on nanobiosensors, which offer ultrasensitive point-of-care diagnosis. Several methods for diagnosing cancer have been discovered and many more are currently being developed. Conventional clinical approaches to detecting cancers are based on a biopsy followed by histopathology, or on the use of biomarkers (protein levels or nucleic acid content). Biopsy is the most widely used technique; however, it is an invasive technique and is not always applicable. Furthermore, biomarker-based detection cannot be relied on when the biomarkers are present in an extremely low concentration in the body fluids and in malignant tissues. Thus, in recent years highly sensitive and robust new cancer diagnosis techniques have been developed for clinical application, and may offer an alternative strategy for cancer diagnosis. As such, this book gathers the latest point-of-care cancer diagnostic methods and protocols based on biomedical sensors, microfluidics, and integrated systems engineering. It also discusses recent developments and diagnostics tests that can be conducted outside the laboratory in remote areas. These technologies include electrochemical sensors, paper-based microfluidics, and other kit-based diagnostic methods that can be adapted to bring cancer detection and diagnostics to more remote settings around the globe. Overall, the book provides students, researchers, and clinicians alike a comprehensive overview of interdisciplinary approaches to cancer diagnosis. 606 $aCancer$xResearch 606 $aBiomedical engineering 606 $aBiology?Technique 606 $aNanotechnology 606 $aNanochemistry 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 606 $aBiomedical Engineering/Biotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/B24000 606 $aBiological Techniques$3https://scigraph.springernature.com/ontologies/product-market-codes/L28000 606 $aNanotechnology and Microengineering$3https://scigraph.springernature.com/ontologies/product-market-codes/T18000 606 $aNanochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/C33000 615 0$aCancer$xResearch. 615 0$aBiomedical engineering. 615 0$aBiology?Technique. 615 0$aNanotechnology. 615 0$aNanochemistry. 615 14$aCancer Research. 615 24$aBiomedical Engineering/Biotechnology. 615 24$aBiological Techniques. 615 24$aNanotechnology and Microengineering. 615 24$aNanochemistry. 676 $a614.5999 702 $aChandra$b Pranjal$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aTan$b Yen Nee$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aSingh$b Surinder P$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910253949003321 996 $aNext Generation Point-of-care Biomedical Sensors Technologies for Cancer Diagnosis$92233541 997 $aUNINA